"EBR will target 45 practices that participated in the trials, aiming for 6 sales each for $US 35000 in their first year after FDA Approval."
Aiming for - but it is a possibility...
'We can assume 100% growth."
OK. Let's keep going with this, but big call ..
"so I didn’t allow for costs in the earnings per share field"
Wait - are you saying the gross revenue number was plugged into earnings??? Surely not. Quite possible less than zero earnings depending on all the costs in the first 12 months of hitting the market. Pulling up the latest P&L will give a rough idea.
However, seeing the pop in SP today, perhaps you are right!
"EBR will target 45 practices that participated in the trials,...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $357.4M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.16 | $127.0K | 108.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6895 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 819 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |